IBOV 169,672.46 ▼ 0.08% IPC MEX 70,388.96 ▼ 1.15% MERVAL 2,848,945 — — USD/BRL5.78▲ 0.03% USD/MXN18.59▲ 0.95% USD/CLP1,000▲ 0.76% USD/COP3,315▼ 0.08% USD/PEN3.41▲ 0.05% USD/ARS1,557▲ 0.31% USD/UYU40.61▲ 3.30% USD/PYG6,212▲ 3.32% USD/BOB11.64▲ 3.07% USD/DOP60.14▼ 0.27% USD/CRC441.73▲ 2.50% USD/GTQ7.64▲ 3.28% USD/HNL26.89▼ 0.10% USD/NIO36.62▲ 0.34% USD/VES913.46▼ 0.22% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD157.39▲ 2.57% USD/TTD6.70▲ 1.98% EUR/BRL6.35▼ 0.08% BRENT 90.18 ▼ 3.18% WTI 84.13 ▼ 2.19% IRON ORE 161.91 — — COPPER 5.70 ▼ 4.60% GOLD 3,778 ▼ 2.24% SILVER 45.48 ▼ 3.82% SOY 1,222 ▼ 0.29% CORN 444.25 ▼ 0.56% WHEAT 603.25 ▲ 1.34% COFFEE 276.60 ▼ 3.49% SUGAR 18.06 ▼ 0.61% ORANGE JUICE 132.25 ▼ 2.04% COTTON 80.95 ▲ 4.69% COCOA 5,065 ▲ 0.70% BEEF 218.70 ▼ 0.74% CATTLE 335.50 ▼ 0.56% LITHIUM 55.70 ▼ 1.28% PETR4 43.96 ▼ 0.05% VALE3 59.77 ▼ 0.94% ITUB4 40.82 ▼ 0.17% BBDC4 14.46 ▲ 0.35% ABEV3 15.95 ▲ 0.13% BBAS3 14.57 ▼ 0.34% B3SA3 14.49 ▼ 1.09% WEGE3 51.87 ▲ 1.41% PRIO3 63.60 ▼ 0.56% SUZB3 56.21 ▲ 1.48% RENT3 29.88 ▲ 0.74% AZZA3 16.01 ▲ 2.37% CSAN3 3.22 ▼ 0.92% RAIZ4 18.49 ▼ 3.24% PCAR3 3.07 ▲ 6.23% GMAT3 4.17 ▼ 0.24% PSSA3 45.58 ▼ 0.74% CVCB3 0.77 ▼ 1.28% POSI3 3.13 — 0.00% SLCE3 18.18 ▲ 0.66% NATU3 4.75 — 0.00% BRKM5 2.76 ▲ 0.36% RANI3 8.16 ▼ 0.73% CSNA3 3.84 ▲ 1.86% IBOV 169,672.46 ▼ 0.08% IPC MEX 70,388.96 ▼ 1.15% MERVAL 2,848,945 — — USD/BRL 5.80 ▲ 0.27% USD/MXN 18.60 ▲ 0.99% USD/CLP 999.18 ▲ 0.64% USD/COP 3,317 ▼ 0.01% USD/PEN 3.41 ▲ 0.05% USD/ARS 1,557 ▲ 0.31% USD/UYU 40.61 ▲ 3.30% USD/PYG 6,212 ▲ 3.32% USD/BOB 11.64 ▲ 3.07% USD/DOP 60.01 ▼ 0.48% USD/CRC 441.73 ▲ 2.50% USD/GTQ 7.64 ▲ 3.28% USD/HNL 26.89 ▼ 0.10% USD/NIO 36.62 ▲ 0.34% USD/VES 913.46 ▼ 0.22% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.39 ▲ 2.57% USD/TTD 6.70 ▲ 1.98% EUR/BRL 6.36 ▲ 0.07% BRENT 90.18 ▼ 3.18% WTI 84.13 ▼ 2.19% IRON ORE 161.91 — — COPPER 5.70 ▼ 4.60% GOLD 3,778 ▼ 2.24% SILVER 45.48 ▼ 3.82% SOY 1,222 ▼ 0.29% CORN 444.25 ▼ 0.56% WHEAT 603.25 ▲ 1.34% COFFEE 276.60 ▼ 3.49% SUGAR 18.06 ▼ 0.61% ORANGE JUICE 132.25 ▼ 2.04% COTTON 80.95 ▲ 4.69% COCOA 5,065 ▲ 0.70% BEEF 218.70 ▼ 0.74% CATTLE 335.50 ▼ 0.56% LITHIUM 55.70 ▼ 1.28% PETR4 43.96 ▼ 0.05% VALE3 59.77 ▼ 0.94% ITUB4 40.82 ▼ 0.17% BBDC4 14.46 ▲ 0.35% ABEV3 15.95 ▲ 0.13% BBAS3 14.57 ▼ 0.34% B3SA3 14.49 ▼ 1.09% WEGE3 51.87 ▲ 1.41% PRIO3 63.60 ▼ 0.56% SUZB3 56.21 ▲ 1.48% RENT3 29.88 ▲ 0.74% AZZA3 16.01 ▲ 2.37% CSAN3 3.22 ▼ 0.92% RAIZ4 18.49 ▼ 3.24% PCAR3 3.07 ▲ 6.23% GMAT3 4.17 ▼ 0.24% PSSA3 45.58 ▼ 0.74% CVCB3 0.77 ▼ 1.28% POSI3 3.13 — 0.00% SLCE3 18.18 ▲ 0.66% NATU3 4.75 — 0.00% BRKM5 2.76 ▲ 0.36% RANI3 8.16 ▼ 0.73% CSNA3 3.84 ▲ 1.86%
since 2009
Wednesday, November 18, 2026

Brazil Life & Society

Vaccine Developed in US Could Prevent Spread of Coronavirus

By · · 3 min read

RIO DE JANEIRO, BRAZIL – US scientists are working to develop a vaccine that could block the coronavirus which has so far infected nearly 8,000 people in several countries and killed nearly 200 people. The vaccine could start being tested within a few months.

Inovio pharmaceutical company’s laboratory in San Diego, California, is currently one of the centers where the vaccine is being developed. Scientists at Inovio hope to have the product ready to be tested in humans by early summer and have already given it a name: the “INO-4800”.

coronavirus-vial
The coronavirus has so far infected nearly 8,000 people in several countries and killed nearly 200 people.
RT
Ask Rio Times
This story and the bigger picture.
Open the full Ask Rio Times →

The fact that the Chinese authorities were quick to release the genetic code for the virus helped the scientists determine its source, mutations it may undergo as the outbreak develops, and how best to protect the world’s population from contagion.

“As soon as China supplied the virus’ DNA sequence, we managed to load it into our computer technology and develop the prototype of a vaccine in just three hours,” Kate Broderick, vice president of research and development at Inovio, explained to the BBC.

Should initial trials be successful, more trials will be carried out, particularly in China, which could happen by the end of this year. If the timeline set by Inovio is confirmed, this will be the fastest developed and tested vaccine in an outbreak scenario.

The LatAm Brief

One email, every weekday morning. What moved in Latin American markets, politics and expat life.

Yesterday’s subject line: “US Embassy warns Americans of Colombia strike Thursday”

The last time a similar virus emerged in 2002 – Severe Acute Respiratory Syndrome (SARS) – China took its time to share information with the world, so the epidemic was already nearing its end when a vaccine was developed.

How the coronavirus vaccine works

The team behind the vaccine development uses new DNA technology and works with a biotechnology company in Beijing.

“Our vaccines are a breakthrough because they use the DNA sequences of the virus to target specific parts of the pathogen,” an organism capable of producing infectious diseases for its hosts, explained the head of the US company.

“Then we use the patient’s own cells as a vaccine manufacturing plant, strengthening the body’s natural response mechanisms”.

The work of this and other laboratories is financed by the Coalition for Epidemic Preparedness Innovations (CEPI), a non-governmental organization that supports the development of vaccines that prevent outbreaks.

“Our mission is to ensure that outbreaks are not a threat to humanity,” explained Melanie Saville, one of the organization’s directors, created following the Ebola outbreak in West Africa.

The World Health Organization (WHO), one of the organizations involved in the global demand for a vaccine to fight the coronavirus, says there is no guarantee that any of the projects under development will be safe and effective enough to be used.

“Experts will consider various criteria, including vaccine safety, immune responses and the availability of laboratories to manufacture sufficient doses within the time required,” the WHO spokesperson explained.

Source: Agência Brasil

This article was produced by The Rio Times’ automated AI newsroom. Editorial responsibility: Matthias Camenzind, Publisher and Editor-in-Chief. The Rio Times also runs Ask Rio Times, which answers from 100,000+ of our own articles, the daily Latin America Power Map, and prediction-market odds on elections and markets.. How we use AI · Report an error

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map →

Brazil runoff date: Sunday, October 25, poll closing times and when results start · Brazil runoff polls: Flávio 51%, Lula 49% · Kalshi and Polymarket odds

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.